Occudo Quantitative Strategies LP Cooper Companies, Inc. Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$315.92 - $397.36 $803,068 - $1.01 Million	2,542 New	2,542 $808,000
Q3 2022 Nov 14, 2022	BUY	$263.81 - $337.27 $2.82 Million - $3.61 Million	10,704 Added 100.34%	21,372 $5.64 Million
Q2 2022 Aug 15, 2022	BUY	$301.4 - $428.42 $1.43 Million - $2.03 Million	4,742 Added 80.02%	10,668 $3.34 Million
Q1 2022 May 16, 2022	SELL	$379.46 - $424.54 $191,247 - $213,968	-504 Reduced 7.84%	5,926 $2.48 Million
Q4 2021 Feb 14, 2022	BUY	$373.53 - $434.12 $1.31 Million - $1.52 Million	3,494 Added 119.01%	6,430 $2.69 Million
Q3 2021 Nov 15, 2021	SELL	$396.76 - $455.92 $1.44 Million - $1.66 Million	-3,642 Reduced 55.37%	2,936 $1.21 Million
Q2 2021 Aug 16, 2021	BUY	$372.36 - $412.07 $2.45 Million - $2.71 Million	6,578 New	6,578 $2.61 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.